Skip to main content
Clinical Trials/CTRI/2017/11/010357
CTRI/2017/11/010357RecruitingPhase 2

AN OPEN CLINICAL STUDY ON UTHIRAVATHA SURONITHAM(RHEUMATOID ARTHRITIS)WITH THE EVALUATION OF SIDDHA TRIAL DRUG VATHA RATCHASAN MATHTHIRAI

GOVERNMENT SIDDHA MEDICAL COLLEGE0 sites20 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • Age 18 to 50 years
  • Willing to participate in trial and signing in consent proforma
  • History of Rheumatoid Arthritis (Anti CCP and RA positive)
  • Morning stiffness
  • Three or more join pain

Exclusion Criteria

  • Rheumatic fever
  • Psoriatic arthropathica
  • Gouty arthritis
  • Systemic lupus erythematous
  • H/O of Sulphur allergy
  • Progressive systemic sclerosis(PSS)

Investigators

Sponsor
GOVERNMENT SIDDHA MEDICAL COLLEGE

Similar Trials